What does Chongqing Lummy Pharmaceutical Co., Ltd. do?

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 300006.SZ's market cap?

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) has a market capitalization of approximately $6.15 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 300006.SZ pay a dividend?

Yes — Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 300006.SZ profitable?

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

300006.SZ

Chongqing Lummy Pharmaceutical Co., Ltd.

SHZ·Drug Manufacturers, General · Healthcare

¥5.82¥0.04−0.68%

Market cap¥6.15B·Market closed·Aug 27 3:25 AM UTC

Price Chart

¥5.82−¥0.04 (−0.68%)today

−47.15%CAGR −11.98%

Select date range

FromTo

Oct 30, 2009Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.050

Ex-Dividend DateJul 3

Payment DateJul 3

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 11

Last Report DateDec 30

Reported vs Estimate−¥0.08

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥745.50M

Net Income−¥126.75M

Net Margin−17.0%

Operating Cash Flow¥83.10M

Capital Expenditures¥31.48M

Free Cash Flow¥51.63M

Return on Equity−7.3%

Return on Invested Capital−0.4%

Net Cash¥572.53M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 300006.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 300006.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 300006.SZ and 80,000+ other tickers.

About Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and…

CEO: Rongzhao Qiu
Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: SHZ
Employees: 973
Website: www.cqlummy.com

Peers

Peers Tab

002900.SZ

Harbin Medisan Pharmaceutical Co., Ltd.

Cap

¥4.4B

603676.SS

Tibet Weixinkang Medicine Co., Ltd.

Cap

¥4.1B

300683.SZ

Wuhan Hiteck Biological Pharma Co.,Ltd

Cap

¥3.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 300006.SZ

What does Chongqing Lummy Pharmaceutical Co., Ltd. do?: Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 300006.SZ's market cap?: Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) has a market capitalization of approximately $6.15 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 300006.SZ pay a dividend?: Yes — Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 300006.SZ profitable?: Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.